Contrave, A New Weight Loss Pill Combines Anti-Addiction Medication And An Antidepressant.
An wizard hortatory panel recommended on Tuesday that Contrave, a unexplored weight-loss nuisance that combines an antidepressant with an anti-addiction medication, be approved by the US Food and Drug Administration. The 13-7 ticket in favor of Contrave came surrounded by agency concerns that the numb might raise blood pressure in some patients and increase the danger of heart attacks and strokes among some users, according to the Associated Press website here. But panelists voted 11-8 earlier in the time that those implied health risks could be studied after Contrave was approved.
The FDA does not have to follow the guidance of its advisory committees, but it typically does. The medium is expected to make a decision on Contrave by Jan 31, 2011, the wire benefit reported. Contrave is manufactured by Orexigen Therapeutics Inc. In October, the FDA voted against approving two other weight-loss drugs, Arena Pharmaceuticals' lorcaserin and Vivus' Qnexa, because of security concerns, according to the AP. Last July, a inspect funded by Orexigen and published in The Lancet found that Contrave helped users lean-to pounds when bewitched along with a shape victuals and exercise.
People who took the drug for more than a year lost an mean of 5 percent or more of body weight, depending on the dose used, the tandem said. However, the regimen did come with side effects, and about half of consider participants dropped out before completing a year of treatment. Contrave is coalition of two well-known drugs, naltrexone (Revia, employed to fight addictions) and the antidepressant bupropion (known by a swarm of names, including Wellbutrin).
The drug appears to boost albatross loss by changing the workings of the body's central nervous system, the researchers said. The sanctum enrolled men (15 percent) and women (85 percent) from around the country, ranging in adulthood from 18 to 65. They were all either pudgy or overweightm, with lofty blood fat levels or high blood pressure.
